Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duccio Medini

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Current Opinion in Microbiology|December 9, 2014
Ten years of pan-genome analysesGeorge Vernikos, Duccio Medini, David R Riley, et al.
Current Opinion in Genetics & Development|September 28, 2005
The microbial pan-genomeDuccio Medini, Claudio Donati, Hervé Tettelin, et al.
Current Opinion in Microbiology|August 8, 2006
Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approachMarirosa Mora, Claudio Donati, Duccio Medini, et al.
BMC Infectious Diseases|December 13, 2021
A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence modelLorenzo Argante, Victoria Abbing-Karahagopian, Kumaran Vadivelu, et al.
American Journal of Epidemiology|November 9, 2021
Evaluating the Impact of Meningococcal Vaccines With Synthetic ControlsOttavia Prunas, Daniel M Weinberger, Duccio Medini, et al.
Scientific Reports|February 27, 2024
Deep-learning image analysis for high-throughput screening of opsono-phagocytosis-promoting monoclonal antibodies against Neisseria gonorrhoeaeFabiola Vacca, Dario Cardamone, Emanuele Andreano, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 30, 2010
Building an insurance against modern pandemicsRino Rappuoli, Duccio Medini, Emilio Siena, et al.
Briefings in Bioinformatics|July 3, 2024
Antibody design using deep learning: from sequence and structure design to affinity maturationSara Joubbi, Alessio Micheli, Paolo Milazzo, et al.
Vaccine|January 11, 2012
The challenge of post-implementation surveillance for novel meningococcal vaccinesMatthew D Snape, Duccio Medini, Scott A Halperin, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 21, 2021
A quantitative systems pharmacology approach to support mRNA vaccine development and optimizationGianluca Selvaggio, Lorena Leonardelli, Giuseppe Lofano, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Current Opinion in Microbiology|December 9, 2014
Ten years of pan-genome analysesGeorge Vernikos, Duccio Medini, David R Riley, et al.
Current Opinion in Genetics & Development|September 28, 2005
The microbial pan-genomeDuccio Medini, Claudio Donati, Hervé Tettelin, et al.
Current Opinion in Microbiology|August 8, 2006
Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approachMarirosa Mora, Claudio Donati, Duccio Medini, et al.
BMC Infectious Diseases|December 13, 2021
A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence modelLorenzo Argante, Victoria Abbing-Karahagopian, Kumaran Vadivelu, et al.
American Journal of Epidemiology|November 9, 2021
Evaluating the Impact of Meningococcal Vaccines With Synthetic ControlsOttavia Prunas, Daniel M Weinberger, Duccio Medini, et al.
Scientific Reports|February 27, 2024
Deep-learning image analysis for high-throughput screening of opsono-phagocytosis-promoting monoclonal antibodies against Neisseria gonorrhoeaeFabiola Vacca, Dario Cardamone, Emanuele Andreano, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 30, 2010
Building an insurance against modern pandemicsRino Rappuoli, Duccio Medini, Emilio Siena, et al.
Briefings in Bioinformatics|July 3, 2024
Antibody design using deep learning: from sequence and structure design to affinity maturationSara Joubbi, Alessio Micheli, Paolo Milazzo, et al.
Vaccine|January 11, 2012
The challenge of post-implementation surveillance for novel meningococcal vaccinesMatthew D Snape, Duccio Medini, Scott A Halperin, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 21, 2021
A quantitative systems pharmacology approach to support mRNA vaccine development and optimizationGianluca Selvaggio, Lorena Leonardelli, Giuseppe Lofano, et al.
Pageof 6